Search the Newsreel

Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead

Immunocore's primary product, Kimmtrak, generated $400 million in sales in 2025, demonstrating strong growth potential, especially with new five-year survival data supporting its first-line positioning for metastatic uveal melanoma. The company has significant catalysts ahead in 2026, including potential expansion into larger cutaneous melanoma …

Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth?

Immunocore Holdings (IMCR) presents a mixed investment profile despite strong Kimmtrak sales growth, with revenues up 14% year-over-year but missing analyst estimates. The company maintains a robust cash position of $844.9 million, funding a pipeline of late-stage and early-stage programs. However, its valuation trades …

Immunocore Holdings PLC (IMCR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Immunocore Holdings PLC (IMCR). It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent payouts. The page also presents current stock performance data, including …

Immunocore Holdings PLC (IMCR) Cash Flow

This article provides a detailed cash flow statement for Immunocore Holdings PLC (IMCR), covering operating, investing, and financing activities across various quarters and fiscal years. It includes specific financial figures and percentage changes for different cash flow components. Additionally, the article offers FAQs explaining …

Immunocore Holdings PLC (IMCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for Immunocore Holdings PLC (IMCR), focusing on regional contributions. As of April 6, the company's revenue is primarily driven by the United States (64.25%) and Europe (32.85%), with a smaller portion from International markets. Information regarding collaboration revenue …

Immuncore Holdings PLC IMCR Income Statement

This article presents the quarterly and annual income statements for Immunocore Holdings PLC (IMCR), offering a detailed breakdown of its financial performance over several years. It includes key metrics such as total revenue, cost of revenue, operating expenses, net income, and earnings per share. …

IMCR|Immunocore Holdings PLC|Price:35.000|Chg%:-0.510

Immunocore Holdings PLC (IMCR) is trading at $35.000, down 1.44%. The company, a U.K.-based biotechnology firm, has strong fundamentals and high growth potential, with its revenue growing 60.37% year-on-year over the past three years. Analysts rate the stock as "Buy" with a target price …

US45258DAA3 Bond Profile — Key Metrics

This article provides a detailed profile of the Immunocore Holdings plc 2.5% 01-FEB-2030 bond (US45258DAA3). It outlines key facts such as the issuer, issue and maturity dates, coupon rate, and face value. The company, Immunocore Holdings Plc, is described as a commercial-stage biotechnology firm …

US45258DAA3 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the Immunocore Holdings plc 2.5% 01-FEB-2030 bond (US45258DAA3). It highlights the current coupon rate of 2.50% and indicates that the next payment is scheduled for August 3, 2026. The page offers an overview of the bond's interest …

US45258DAA3 Bond Risk Profile

This article provides a risk profile for the US45258DAA3 bond issued by Immunocore Holdings plc, offering an overview of its coupon and redemption details. It highlights key metrics for credit risk assessment, including security level and issuer rating. The platform also suggests accessing exclusive …

(IMCR) Volatility Zones as Tactical Triggers

This article analyzes Immunocore Holdings Plc (IMCR) using AI-generated volatility zones and tactical triggers. It highlights a strong near and mid-term sentiment, although the long-term outlook is weak, with no resistance levels identified above the current price. The analysis provides specific trading strategies—Position, Momentum …

IMCR5997845 Bond Coupon Profile — Rate & Payments

This article provides the coupon profile for the Immunocore Holdings plc (IMCR5997845) bond, detailing its interest rate and payment schedule. The bond has a current coupon rate of 2.50%, with the next payment scheduled for August 3, 2026. The information is presented by TradingView, …

A Look At Immunocore (IMCR) Valuation After Strong Q1 2026 Results And New KIMMTRAK Survival Data

Immunocore (IMCR) Is Up 10.1% After Q1 Profitability Jumps On Higher Revenue And Efficiency

IMCR Financials: Income Statement, Balance Sheet & Cash Flow | Immunocore Holdings Plc